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bidity and mortality, but also to maintain cost-effective
care.
Hyperlactatemia on admission to the cardiac intensive
care unit (CICU) has been proposed as a potentially
sensitive and specific marker for adverse outcome. Data
from recent studies are summarized in Table I.1-5 As
demonstrated in the table, no specific lactate level has
been a consistent indicator of outcome. Although the
peak lactate level may indicate low cardiac output or
reduced tissue oxygen extraction, the change in lactate
level over time may be a more reliable marker of the
response to therapeutic interventions and subsequent
outcome. The studies cited have primarily examined
lactate levels on admission to the CICU, yet the initial
stimulus for lactate production may occur during car-
diopulmonary bypass (CPB). The duration of CPB,
duration of circulatory arrest, the degree of hypother-
mia, duration of cooling and rewarming, pH manage-
ment strategy, and hematocrit value are all potential fac-
tors that may contribute to hypoperfusion during CPB.
In addition, surgical considerations such as impaired
R eliable indicators of morbidity and mortality afteroperations for congenital cardiac disease have been
difficult to determine. Continuous invasive monitoring
is often limited, particularly in neonates and infants.
Nevertheless, the development of a reliable indicator of
outcome is an important goal, not only to improve mor-
Objective: Our objective was to evaluate the change in lactate level dur-
ing cardiopulmonary bypass and the possible predictive value in identi-
fying patients at high risk of morbidity and mortality after surgery for
congenital cardiac disease. Methods: We prospectively studied lactate lev-
els in 174 nonconsecutive patients undergoing cardiopulmonary bypass
during operations for congenital cardiac disease. Arterial blood samples
were taken before cardiopulmonary bypass, during cardiopulmonary
bypass (cooling and rewarming), after cardiopulmonary bypass, and
during admission to the cardiac intensive care unit. Complicated out-
comes were defined as open sternum as a response to cardiopulmonary
instability, renal failure, cardiac arrest and resuscitation, extracorpore-
al membrane oxygenation, and death. Results: The largest increment in
lactate level occurred during cardiopulmonary bypass. Lactate levels
decreased between the postbypass period and on admission to the inten-
sive care unit. Patients who had circulatory arrest exhibited higher lac-
tate levels at all time points. Nonsurvivors had higher lactate levels at all
time points. A change in lactate level of more than 3 mmol/L during car-
diopulmonary bypass had the optimal sensitivity (82%) and specificity
(80%) for mortality, although the positive predictive value was low.
Conclusions: Hyperlactatemia occurs during cardiopulmonary bypass
in patients undergoing operations for congenital cardiac disease and
may be an early indicator for postoperative morbidity and mortality.
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venous drainage or anatomic lesions characterized by
reduced splanchnic flow or excessive systemic runoff
may limit perfusion. Finally, the systemic inflammato-
ry response to CPB, which is heightened in neonates
and infants, may also impair organ perfusion and per-
haps, more specifically, tissue oxygen extraction.
This study examines the change in whole blood lac-
tate level during CPB and the possible role in identify-
ing patients at high risk for morbidity and mortality
after operations for congenital cardiac disease. 
Patients and methods
The study was approved by the Institutional Review Board
of Children’s Hospital, Boston, and written informed consent
was obtained from parents or from subjects older than 17
years of age. A prospective observational study of 174 non-
consecutive patients undergoing CPB with or without circu-
latory arrest for surgery for congenital cardiac disease was
conducted between March 1996 and April 1998. This group
represents 13% of all patients who underwent CPB at our
institution during the study period. Patients for the study were
selected by convenience sampling, without randomization or
control of surgical procedure, conduct of anesthesia, or CPB
management. The patients enrolled were primarily either in
the CICU before the operation or had been admitted to the
hospital before the operation. Thus there was a selection bias
toward patients with more complicated congenital defects and
operations. 
After induction of anesthesia and placement of an intra-
arterial catheter, 1 mL of arterial blood was collected into a
heparinized blood gas syringe and immediately analyzed on
the Ultra C analyzer (Nova Biomedical, Waltham, Mass) for
blood gas, lactate, hematocrit, electrolytes, magnesium, Ca2+,
and glucose. Quality controls were performed on the analyz-
er before laboratory determinations. Samples were not drawn
at specific time points, but rather within 5 time intervals:
before CPB, during cooling on CPB, during rewarming on
CPB, immediately after CPB in the operating room, and after
admission to the CICU. The lactate level in the extracorpore-
al circuit after initial priming and before CPB was not
measured.
Differences in lactate levels related to patient age, weight,
and diagnosis were examined. To examine the effect of
patient diagnosis and surgical complexity on serum lactate
level and outcome, we separated patients into complexity cat-
egories as previously described by Jenkins and colleagues.6
This classification does not include heart transplantation, and
those patients in our study (n = 3) were excluded from the
analysis. Patient mortality and the prevalence of postopera-
tive complications for each of the 4 complexity categories rel-
ative to the change in lactate were examined.
On CICU admission, the severity of illness for each patient
was assessed by means of the Pediatric Severity of Illness
score (PRISM III).7 Patients were categorized as having a
complicated postoperative outcome if they demonstrated one
or more of the following events: (1) renal insufficiency with
a serum creatinine level of more than 1.5 mg/dL in the CICU,
(2) cardiac arrest and resuscitation, (3) extracorporeal mem-
brane oxygenation, (4) open sternum as a response to car-
diopulmonary instability either in the operating room or after
emergency chest reopening in the CICU, and (5) death. In
addition to these adverse events, the duration of mechanical
ventilation and length of CICU stay were also examined.
The change in lactate during CPB was defined as the dif-
ference between baseline (median 47 minutes before CPB)
and the first lactate value obtained after CPB (median 9 min-
utes). Duration of CPB was defined as the total elapsed time
from the institution of CPB until discontinuation of CPB at
the end of surgical repair. This period included circulatory
arrest time. During CPB, the change in lactate level was eval-
uated relative to duration of CPB, duration of circulatory
arrest, duration of cooling, duration of rewarming, nadir tem-
perature, blood gas strategy, and hematocrit. The relation-
ships between patient complications including death and the
change in lactate level during CPB and the absolute lactate
level on admission to the CICU were examined.
Statistical analysis. Because they are not normally distrib-
Table I. Hyperlactatemia on ICU admission: PPV, sensitivity, and specificity for morbidity and mortality
Lactate on ICU admission 
Patients associated with complications 
Author No. Died Age including death (mmol/L) Comment
Siegel et al, 19951 41 7 2 mo–16 y 6.9 ± 0.8* Range 3.9 to 10.2
Shemie et al, 19962 109 8 1 d–19 y 13.7 ± 8.9* >5 mmol/L: 75% sensitivity, 84% specificity 
for complication
Cheifetz et al, 19973 48 6 <12 mo 13.7 ± 2.4* <7 mmol/L: 100% sensitivity for survival
Hatherill et al, 19974 99 9 0.4-31 mo 8.7 (1.9-17.6)† >6 mmol/L; 50% sensitivity, 90% specificity
for complication. PPV 68%
Duke et al, 19975 90 4 0.5-5.75 mo 3.0 (2.1- 4.9)† > 4.5 mmol/L on ICU admission, odds ratio 
(95% CI) for complication 5.1 (1.2-21.1)
ICU, Intensive care unit; PPV, positive predictive value; CI, confidence interval.
*Mean ± standard deviation. 
†Median (range).
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uted, lactate levels were analyzed by means of nonparametric
methods. Medians were compared by means of the Wilcoxon
signed-rank test for paired data, the rank sum test for 2 inde-
pendent groups, and the Kruskal-Wallis test for more than 2
groups. The Wilcoxon signed-rank test was used to compare
median lactate levels over time, with a Bonferroni correction
for multiple comparisons. The Spearman rank correlation
coefficient was used to look for relationships between lactate
change during CPB and continuous measures. The Fisher
exact test was used to compare proportions. The following
outcome variables were analyzed: PRISM III score, duration
of mechanical ventilation, CICU stay, complications, and
mortality. To control for other covariates, we used linear
regression methods for continuous outcomes and logistic
regression for binary outcomes. A log transformation was
used for continuous outcomes that were not normally distrib-
uted. The receiver operator characteristic curve was used to
optimize sensitivity and specificity when using a change of
lactate level during CPB to predict mortality. Analyses were
performed with the Stata statistical package (Stata
Corporation, College Station, Tex).
Results
For the 174 patients studied (68 female and 106 male
patients), the median age was 0.8 years with a range of
1 day to 39.8 years; the median weight was 7.3 kg
(range 1.9-94 kg).
Table II. Categories of surgical complexity, surgical description, mortality, and complications
Died Complication 
Category Surgical description (n) No. % No. %
1 (n = 26) ASD (n = 23) 0 0 0 0
PAB (n = 3)
2 (n = 56) Open valvotomy (n = 3) 2 3.6 4 7.1
Subaortic stenosis resection (n = 2)
VSD (n = 25)
AVC (n = 6)
TOF (n = 12)
Thoracic vessel repair, prosthesis (n = 2)
Septal surgery, unspecified (n = 4)
Operations adjacent to heart valves (n = 2)
3 (n = 45) Valve replacement (n = 3) 1 2.2 10 22
TAPVR (n = 1)
Truncus arteriosus (n = 4)
RV-PA conduit (n = 18)
LV-Ao conduit (n = 2)
Cavopulmonary shunt (n = 10)
AP window (n = 7)
4 (n = 44) ASO (n = 14) 10 23 16 36
Fontan (n = 14)
Norwood (n = 16)
P value* .001 <.001
ASD, Atrial septal defect; PAB, pulmonary artery band; VSD, ventricular septal defect; AVC, atrioventricular canal; TOF, tetralogy of Fallot; TAPVR, total anomalous
pulmonary venous connection; RV, right ventricle; PA, pulmonary artery; LV, left ventricle; Ao, aorta; AP, aortopulmonary; ASO, arterial switch operation. Heart trans-
plants (n = 3, deaths = 1) were excluded from the surgical categories.
*Comparing proportions of complications and mortality among categories of surgical complexity by the Fisher exact test.
Table III. Categories of surgical complexity and lactate levels at each time point of the perioperative period
Category Baseline Cooling Rewarming After CPB CICU admission
1 1.2 1.8 2.2 2.2 2.0
(0.9-1.6) (1.6-2.3) (1.9-3.7) (1.8-3.6) (1.2-3.4)
2 1.1 1.6 2.3 2.3 2.1
(0.8-1.4) (1.1-2.4) (1.6-3.5) (1.6-3.4) (1.3-2.7)
3 1.1 1.7 2.3 2.7 1.9
(0.7-1.4) (1.2-2.3) (1.8-4.5) (2.0-4.7) (1.4-4.5)
4 1.5 2.5 4.9 5.1 4.3
(1.0-2.6) (1.7-4.5) (2.2-6.5) (2.4-6.5) (2.0-7.8)
Data are expressed as median (25th and 75th percentiles). CPB, Cardiopulmonary bypass; CICU, cardiac intensive care unit.
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The change in lactate level during CPB increased
with surgical complexity (P = .002). With increasing
surgical complexity, there was an increase in postoper-
ative complications, as expected (P < .001, Table II).
Summary statistics for the lactate levels for each surgi-
cal complexity category after induction of anesthesia,
cooling on CPB, rewarming on CPB, immediately
after CPB, and on admission to the CICU are shown in
Table III.
Change in lactate level during CPB. The median
age, weight, and CPB characteristics for patients
without complications, patients who died, and
patients who had at least 1 postoperative complication
are shown in Table IV. An increase in median lac-
tate level was noted from baseline versus cooling
(P < .0001), cooling versus rewarming (P < .0001),
and rewarming versus the post-CPB period (P =
.0002) and a decrease in lactate level between the
immediate post-CPB period and admission to the CICU
(P = .01) (Fig 1). All differences remained statistically
Table IV. Age, weight, and CPB characteristics between survivors, with and without complications, and nonsurvivors
Survivors without Survivors with 
complications complications Nonsurvivors 
(n = 142) (n = 18) (n = 14) P value*
Age 1.4 y 12 d 5 d <.001
(75 d–6.7 y) (5 d–1.7 y) (2–18 d)
Weight (kg) 9 3.6 2.8 <.001
(4.4-17.3) (3.2-9.7) (2.3-4.5)
CPB time (min) 88.5 127 173.5 <.001
(62-123) (109-160) (124-219)
Circulatory arrest time (min)† 22 41 44 .02
(10-38) (31-54) (16-51)
Duration of cooling (min) 20 31 26 .06
(12-30) (18-46) (20-50)
Duration of rewarming (min) 27 33 43.5 <.001
(20-33) (27-39) (35-50)
Hematocrit cooling (%) 24 23 25.5 >.2
(21-26) (21-28) (22-28)
Hematocrit rewarming (%) 26 27 28 .02
(22-29) (24-30) (27-32)
Data are expressed as median (25th and 75th percentiles). CPB, Cardiopulmonary bypass.
*Comparison of all 3 groups by Kruskal-Wallis test.
†Median for the number of patients undergoing circulatory arrest in each group, that is, 39 of 142 survivors without complications, 9 of 18 survivors with complica-
tions, and 13 of 14 nonsurvivors.
Table V. Median lactate levels between survivors, with and without complications, and nonsurvivors
Survivors without Survivors with 
complications complications Nonsurvivors 
(n = 142) (n = 18) (n = 14) P value*
Baseline 1.1 1.2 2.0 .01
(0.8-1.5) (0.9-2.4) (1.3-2.7)
Cooling 1.7 2.3 4.1 <.001
(1.2-2.4) (1.9-3.1) (2.4-4.9)
Rewarming 2.3 4.1 7.4 <.001
(1.6-3.7) (2.3-5.4) (4.2-7.8)
After CPB 2.3 5.1 7.4 <.001
(1.8-4.1) (2.2-6.1) (5.1-10.7)
∆ Lactate during CPB 1.3 3.1 5.0 <.001
(0.7-2.3) (1.2-4.5) (3.1-8)
CICU admission 2.0 4.6 8.5 <.001
(1.3-3.2) (2.1-8.3) (7.8-20)
Data are expressed as median (25th and 75th percentiles). ∆ Lactate, Change in lactate level; CPB, cardiopulmonary bypass; CICU, cardiac intensive care unit.
*Comparison of all 3 groups by Kruskal-Wallis test.
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significant after use of the Bonferroni correction for
multiple comparisons.
The duration of CPB and circulatory arrest was pos-
itively correlated with a change in lactate during CPB
(P < .0001, r
s
= 0.43, and P = .0002, r
s
= 0.47, respec-
tively). The correlation between duration of circulato-
ry arrest and a lactate change during CPB remained
significant after excluding the 16 patients who had
undergone a Norwood procedure (P = .003, rs =
0.43). Patients who had circulatory arrest (n = 61) had
a higher median lactate level at all time points than
did patients without circulatory arrest (n = 113) (Fig
2). Again, all differences remain statistically signifi-
cant after application of a Bonferroni correction. By
univariate analysis, there was no relationship between
the change in lactate level and nadir temperature, low-
est hematocrit value, or blood gas strategy during
CPB.
The median lactate levels for each time point and the
changes in lactate during CPB for survivors without
complications (n = 142), patients who died (n = 14), and
those who had at least 1 postoperative complication (n
= 18) are shown in Table V. Nonsurvivors exhibited a
higher median lactate level at all time points than did
survivors (P < .001) (Fig 3). On the basis of the receiv-
er operator characteristic analysis, a change in lactate
level of more than 3 mmol/L had a sensitivity of 82%
and a specificity of 80% for mortality but a low positive
predictive value of 23%. This change in lactate level had
a positive predictive value of 45% for complications.
Fig 1. Median, 25th, and 75th percentiles of lactate levels at
each time point of the perioperative period. CPB, Cardio-
pulmonary bypass; CICU, cardiac intensive care unit.
Fig 2. Difference in median, 25th, and 75th percentiles of lac-
tate levels between patients with and without circulatory
arrest at each time point of the perioperative period. CPB,
Cardiopulmonary bypass; CICU, cardiac intensive care unit;
CA, circulatory arrest.
Fig 3. Difference in median, 25th, and 75th percentiles of lac-
tate levels between survivors and nonsurvivors at each time
point of the perioperative period. CPB, Cardiopulmonary
bypass; CICU, cardiac intensive care unit.
Fig 4. Receiver operator characteristic curve showing sensi-
tivity and (1 – specificity) of a change (∆) in whole blood lac-
tate levels during cardiopulmonary bypass (CPB) for mortal-
ity. Positive predictive value (PPV) of a lactate change during
cardiopulmonary bypass for mortality and complications.
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Progressive increments in the change in lactate level
during CPB increased the positive predictive value for
mortality and complications as shown in Fig 4.
Lactate level on admission to the CICU. The
PRISM III score on admission to the CICU, incidence
of complications, duration of mechanical ventilation,
and duration of stay in the CICU for survivors and non-
survivors are shown in Table VI. Lactate change during
CPB was correlated with higher PRISM III score on
CICU admission (P < .0001, r
s
= 0.43), longer intuba-
tion time (P < .0001, r
s
= 0.47), and longer CICU stay
(P = .0001, r
s
= 0.45). By means of multivariable
regression models controlling for CPB time, circulato-
ry arrest, Norwood procedure, and neonate status, a
change in lactate level during CPB remained signifi-
cantly associated only with higher PRISM III score on
admission to the CICU (P = .05). Although not statisti-
cally significant, there was a trend for a larger change
in lactate during CPB to be associated with mortality (P
= .13) and complications (P = .06).
Discussion
Although previous reports have noted an association
between hyperlactatemia on CICU admission and mor-
bidity and mortality,1-5 our study demonstrates that the
increase in lactate occurs during CPB and this may be
an early indicator of outcome. In this study, the
increase in lactate during CPB was more common in
patients with complex anatomy or surgical procedures,
was related to the duration of CPB and circulatory
arrest, and was associated with a higher PRISM III
score on admission to the CICU, longer duration of
mechanical ventilation, and longer CICU stay.
An absolute lactate level or range has not been
defined that correlates accurately with morbidity and
mortality, and it is likely that the change in lactate over
time is a better marker of patient outcome. Hatherill
and associates4 reported that a serum lactate level of
more than 6 mmol/L on CICU admission in children
after surgery for congenital cardiac disease had a low
positive predictive value for mortality. In addition,
Hatherill and associates demonstrated a wide range of
CICU admission lactate levels between survivors (0.6-
13. 6 mmol/L) and nonsurvivors (1.9-17.6 mmol/L) in
patients undergoing complex surgical repairs.
However, children who had a complicated postopera-
tive course (defined as end-organ injury) had higher
median initial serum lactate levels than did those
patients who had an uncomplicated course. Similar lac-
tate levels indicating a complicated postoperative
course have also been reported by Shemie2 and Duke
and coworkers.5
Hyperlactatemia measured on admission to the CICU
has been significantly correlated with the duration of
CPB and circulatory arrest, an increased alveolar-arte-
rial oxygen tension gradient, duration of inotropic sup-
port, and duration of mechanical ventilation.1,2,4,5
Although an isolated lactate level of more than 6
mmol/L in the CICU may be a useful indicator for a
complicated postoperative course, it does not discrimi-
nate between survivors and nonsurvivors. Our study
demonstrates that the onset of hyperlactatemia occurs
in the operating room during CPB, and this change in
lactate concentration correlated with a higher PRISM
III score and longer duration of mechanical ventilation
and CICU stay.
Table VI. PRISM III score, duration of mechanical ventilation, CICU stay, and postoperative complications
between survivors, with and without complications, and nonsurvivors
Survivors without Survivors with 
complications complications Nonsurvivors 
(n = 142) (n = 18) (n = 14) P value*
PRISM III score 5 7 12.5 <.001
(2-7) (5-11) (8-14)
Mechanical ventilation (h) 20 158 375 <.001
(8.8-46.5) (28-260) (96-957)
Duration CICU stay (h) 48 223 408 <.001
(25-90) (98-361) (96-957)
Renal insufficiency (n) — 2 3
Cardiac arrest off CPB (n) — 1 2
ECMO (n) — 2 2
Open sternum (n) — 13 8
Data are expressed as median (25th and 75th percentiles) for PRISM III score, duration of mechanical ventilation, and duration of CICU stay. CPB, Cardiopulmonary
bypass; CICU, cardiac intensive care unit; ECMO, extracorporeal membrane oxygenation.
*Comparison of all 3 groups by Kruskal-Wallis test.
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An increase in lactate concentration may be the result
of diminished tissue perfusion and oxygen delivery,
decreased oxygen extraction, and decreased hepatic
lactate clearance.8 Operations for biventricular repair
or palliation of many defects are often complex and
prolonged procedures, necessitating an increased dura-
tion of deep hypothermic CPB with or without circula-
tory arrest. In addition, the disparity between the prime
volume of the CPB circuit and patient’s blood volume
in neonates and infants means that the effects of
hemodilution are magnified. A decrease in hematocrit
value and oncotic pressure may impair oxygen deliv-
ery, and a fall in systemic vascular resistance may
decrease organ perfusion.9 Further, the increased expo-
sure of circulating blood in neonates and infants to the
nonendothelialized surface of the CPB circuit heightens
the systemic inflammatory response, and the release of
cytokines and oxygen-derived free radicals may direct-
ly injure tissue and alter microcirculatory flow.
The adequacy of perfusion during hypothermic CPB
is generally monitored by means of indirect or global
indices of perfusion. The flow rate and perfusion pres-
sure during CPB varies according to the level of
hypothermia, the anticipated surgical complexity, and
the duration of repair. The urine output during CPB
may be an indicator of renal perfusion, although an
association between urine output during CPB and
patient morbidity has not been noted. A fall in mixed
venous oxygen saturation during CPB may occur even
though flow rate and perfusion pressure appear ade-
quate. This reflects increased oxygen extraction from
either inadequate tissue perfusion or increased oxygen
demand, such as during the rewarming process or
under light levels of anesthesia. A mismatch between
oxygen demand and delivery may occur regionally, but
regional blood flow is difficult to monitor during CPB.
The relative cardiac output, vasomotor tone of various
organs, and patency of the microcirculation are altered
during bypass. In addition, regional metabolic demands
may be increased because of nonhomogeneous cooling
and rewarming and as a result of the oxygen debt
incurred from hypoperfusion during CPB. The inflam-
matory response with release of cytokines and the
release of endogenous stress hormones that occur dur-
ing hypothermic CPB will also increase regional meta-
bolic demands.10,11
Although nonspecific, an increase or change in lac-
tate level during CPB may be a marker of regional
hypoperfusion or increased metabolic demand. The
organs most likely to produce lactate in response to
hypoperfusion or decreased oxygen extraction include
the brain, gut, liver, kidneys, and skeletal muscle.12-14
Changes in cerebral blood flow and cerebral metabolic
rate in response to deep hypothermic circulatory arrest
have been described.15 Methods for monitoring cere-
bral oxygen disturbance during CPB include the mea-
surement of jugular venous bulb oxygen saturation and
lactate, and measurement of the redox state of the brain
by near-infrared spectroscopy. These indices have not
been correlated with a change in blood lactate levels.
The integrity of the gastrointestinal tract may also be
altered during CPB. Studies examining the effect of
CPB on splanchnic oxygenation and blood flow have
demonstrated that significant mucosal hypoperfusion
may occur.9,16-18 This may cause an increase in perme-
ability across the bowel wall, contributing to an in-
crease in endotoxin and cytokine levels after CPB.
Splanchnic blood flow may be influenced by a number
of factors. Anatomic defects or surgical repairs associ-
ated with diastolic runoff from an aortopulmonary
communication, such as a patent ductus arteriosus or
modified Blalock-Taussig shunt, may reduce splanch-
nic perfusion. In addition, the splanchnic vascular bed
is influenced by various circulating humoral mediators;
catecholamines, angiotensin II, and vasopressin cause
splanchnic vasoconstriction, and histamine, prosta-
glandin E2, and bradykinin have vasodilator proper-
ties.19 The blood gas management during hypothermic
CPB may also influence splanchnic vascular tone with
an increase in carbon dioxide tension causing an
increase in blood flow. Finally, intestinal mucosal
edema may occur during hypothermic CPB, which
would potentially limit splanchnic perfusion and oxy-
gen extraction.
No interventions during CPB were made in our
patients in response to an increase in lactate level. In
addition, the anesthetic technique varied among
patients, and the specific influence of anesthesia on lac-
tate level could not be examined. Nevertheless, early
recognition of patients at risk for the development of
hyperlactatemia associated with morbidity and mortal-
ity may allow intervention in a timely manner to reduce
their susceptibility to injury. Although we were unable
to determine a relation between a change in lactate and
CPB variables such as hematocrit value and pH man-
agement, potential interventions that may alter organ
perfusion and tissue oxygen use during CPB include
the following: (1) manipulation of perfusion pressure
and flow rates, (2) level of hypothermia and duration of
cooling and rewarming, (3) alteration in the circuit
prime to ensure optimal hematocrit value and oncotic
pressure, (4) ultrafiltration during rewarming or after
separation from CPB, and (5) the use of agents to
specifically modify the systemic inflammatory
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response. We acknowledge that further prospective
studies are necessary to determine whether modifying
the conduct of CPB relative to lactate levels will alter
patient outcome.
Limitations
Because of the nonrandomized method of patient
selection, there was a selection bias toward patients
with more complicated congenital defects, with a high-
er mortality (study mortality rate 8% of 174 patients),
which does not reflect our institutional mortality rate
over that period (2.8% for 1332 patients undergoing
CPB). Nonsurvivors in our study population had slight-
ly higher lactate levels at baseline and a larger change
during CPB than did survivors. This may reflect the
preoperative clinical condition, diagnosis and complex-
ity of the operation, and longer CPB and circulatory
arrest times. Selection of higher risk patients may have
increased the likelihood of correlating lactate content
with adverse outcome.
In conclusion, our study reveals that an intraoperative
increment in lactate level is an early and specific indi-
cator of patients at high risk for morbidity and mortal-
ity after operations for congenital cardiac disease.
Patient diagnosis, surgical complexity, and duration of
circulatory arrest were associated with higher levels of
lactate. Monitoring the lactate concentration during the
phases of hypothermic CPB may be important, but fur-
ther randomized studies relating specific changes in
CPB management in response to a change in lactate
level with patient outcome are necessary.
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